Saturday, January 10, 2009

Plendil


Plendil is a brand name of felodipine, approved by the FDA in the following formulation(s):


PLENDIL (felodipine - tablet, extended release; oral)



  • Manufacturer: ASTRAZENECA

    Approval date: July 25, 1991

    Strength(s): 10MG [AB], 5MG [AB]


  • Manufacturer: ASTRAZENECA

    Approval date: September 22, 1994

    Strength(s): 2.5MG [AB]

Has a generic version of Plendil been approved?


Yes. The following products are equivalent to Plendil:


felodipine tablet, extended release; oral



  • Manufacturer: ENDO PHARMS

    Approval date: October 28, 2011

    Strength(s): 10MG [AB], 2.5MG [AB], 5MG [AB]


  • Manufacturer: GLENMARK GENERICS

    Approval date: December 17, 2010

    Strength(s): 10MG [AB], 2.5MG [AB], 5MG [AB]


  • Manufacturer: MUTUAL PHARM

    Approval date: November 2, 2004

    Strength(s): 10MG [AB], 2.5MG [AB], 5MG [AB]


  • Manufacturer: MYLAN

    Approval date: April 17, 2008

    Strength(s): 2.5MG [AB], 5MG [AB]


  • Manufacturer: TORRENT PHARMS LTD

    Approval date: November 28, 2011

    Strength(s): 10MG [AB], 2.5MG [AB], 5MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Plendil. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Plendil.

See also...

  • Plendil Consumer Information (Drugs.com)
  • Plendil Consumer Information (Wolters Kluwer)
  • Plendil Consumer Information (Cerner Multum)
  • Plendil Advanced Consumer Information (Micromedex)
  • Plendil AHFS DI Monographs (ASHP)
  • Felodipine Consumer Information (Wolters Kluwer)
  • Felodipine Consumer Information (Cerner Multum)
  • Felodipine Advanced Consumer Information (Micromedex)
  • Felodipine AHFS DI Monographs (ASHP)

No comments:

Post a Comment